VERSINO, Elisabetta

VERSINO, Elisabetta  

SCIENZE CLINICHE E BIOLOGICHE  

Mostra records
Risultati 1 - 20 di 133 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autore(i) File
A 4-year multicenter follow-up of neutralizing anti-interferon antibodies in ms patients treated with high dose (375 mcg) interferon beta-1b 2006 A. TAVELLA; A. RICCI; P. BARBERO; A. PIPIERI; A. CUCCI; B. FERRERO; A. ROVERA; G. CONTESSA; M. BERGUI; E. VERSINO; M. CLERICO; L. DURELLI; FOR THE OPTIMS TRIAL STUDY GROUP
A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia. 2019 Covella B; Vinturache AE Cabiddu G; Attini R; Gesualdo L; Versino E; Piccoli GB
Assessing treatment response to immunomodulatory drugs for ms: a single active mri scan after 6 months of treatment is the best indicator of persisting disease activity 2005 L. DURELLI; E. VERDUN; P. BARBERO; M. CLERICO; B. FERRERO; E. VERSINO; G. GIULIANI; E. MONTANARI; THE OPTIMS STUDY GROUP
Best indicator of persisting disease activity 2005 L. DURELLI; E. VERDUN; P. BARBERO; M. CLERICO; B. FERRERO; E. VERSINO; G. GIULIANI; E. MONTANARI; AND THE OPTIMS STUDY GROUP
The best indication to early treat the clinically isolated syndrome based on the clinical onset. A Cochrane analysis 2009 Clerico, M; Versino, E; Contessa, G; Ripellino, P; Palace, J; Tintore, M; Durelli, L
Chronic kidney disease: The complex history of the organization of long-term care and bioethics. why now, more than ever, action is needed 2019 Versino E., Piccoli G.B.
Clinical and laboratory tolerability evaluation of treatment with high-dose interferon beta-1b (500mcg every-other-day, subcutaneously) in ms patients. 2003 A. PIPIERI; P. BARBERO; M. CLERICO; E. VERDUN; E. VERSINO; A. CUCCI; E. PUCCI; E. CARTECHINI; L. MANNESCHI; G. GIULIANI; E. MONTANARI; L. DURELLI
Clinically isolated syndrome: when to treat? A Cochrane analysis 2009 Marinella Clerico; Elisabetta Versino; Giulia Contessa; Jacqueline Palace; Mar Tintore'; Luca Durelli
Comparision of a biological (mxa protein level) and an mri treatment response indicator for interferon beta therapy in multiple sclerosis 2006 G. CONTESSA; M. CLERICO; P. BARBERO; B. FERRERO; A. RICCI; E. VERSINO; G. GIULIANI; E. MONTANARI; L. DURELLI; FOR THE OPTIMS STUDY GROUP
Compulsory Psychiatric Admissions in an Italian Urban Setting: Are They Actually Compliant to the Need for Treatment Criteria or Arranged for Dangerous Not Clinical Condition?. 2019 Oliva F; Ostacoli L; Versino E; Portigliatti Pomeri A; Furlan PM; Carletto S; Picci RL.
Consumo di ecstasy tra i diciottenni della Regione Piemonte convocati per la visita di leva 1999 E. VERSINO; IPPOLITO R; MITOLA B; NICOLAZZO M; SILIQUINI R
Correlation of anti-interferon beta neutralising antobodies with clinical response and mri activity in the INCOMIN (independent comparison of interferon) trial. 2003 P. BARBERO; E. VERDUN; M. CLERICO; A. PIPIERI; A. RICCI; M. BERGUI; E. VERSINO; G. ANTONELLI; M. ZAFFARONI; A. GHEZZI; E. MONTANARI; L. DURELLI; AND INCOMIN STUDY GROUP
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France 2021 Bianchi S, Torreggiani M, Chatrenet A ,Fois A , Mazé B , Njandjo L, Bianco G, Lepori L, Pili A ,Michel PA, Sileno G, Arazzi M, Esposito V, Pani A , Versino E, Esposito C, Fessi H, Cabiddu G, Piccoli GB
Cytokines and Chemokine mRNA in perpheral blood of multiple sclerosis patients correlates with treatment response and interferon beta dose 2008 Giulia Contessa; Marinella Clerico; Angele Cucci; Chiara Rivoiro; Pierangelo Barbero; Bruno Ferrero; Elisabetta Versino; Cinzia Ferrero; Paolo Ripellino; Luca Durelli
Deaths attributable to tobacco smoking in Italy 2008 Mathis F; Vigna-Taglianti F; Migliardi A; Versino E; Faggiano F
Decennial trends of social differentials in smoking habits in Italy 2001 F. FAGGIANO; E. VERSINO; P. LEMMA
I determinanti delle disuguaglianze sociali nella salute in Italia 2000 FAGGIANO F; RENGA G; E. VERSINO
[Determinants of social inequalities in health in Italy] 2000 FAGGIANO F ;RENGA G ;VERSINO E
Diet as a system: an observational study investigating a multi-choice system of moderately restricted low-protein diets 2016 Piccoli, Giorgina Barbara; Nazha, Marta; Capizzi, Irene; Vigotti, Federica Neve; Scognamiglio, Stefania; Consiglio, Valentina; Mongilardi, Elena; Bilocati, Marilisa; Avagnina, Paolo; Versino, Elisabetta
Differenze di genere alla presa in carico al SerT: risultati dallo studio VEdeTTE 2004 Vigna-Taglianti F; Versino E; Burroni P; Beccaria F; Garneri M; Rotelli M; Mathis F; Bertuccio P